Paper: Inhaled Nucleic Acid Therapeutics and Biopharmaceuticals
Originally from Hong Kong, Dr Jenny Lam obtained her MPharm from the University of Nottingham, UK. After being registered as a pharmacist, she continued her PhD study in the University of Nottingham under the supervision of Professor Snow Stolnik, and her project is focused on the development of non-viral vector for gene delivery. After she received the PhD in 2006, she worked in the National Physical Laboratory, UK for a year. In 2007, Dr Lam was awarded the Maplethorpe Fellowship in the Department of Pharmacy at King's College London. Dr Lam joined the Department of Pharmacology and Pharmacy in the University of Hong Kong in 2009 as Assistant Professor, and was promoted to Associate Professor in 2016. She is also the Associate Head (Undergraduate Education) in her department. Her research is focused on the development of novel delivery system for macromolecular therapeutics including nucleic acids, proteins and antimicrobial agents, with special interest in the use of particle engineering methods to produce inhaled and nasal dry powder formulations for the treatment/prevention of respiratory diseases. She is the principal investigator of a number of research projects funded by Research Grant Council (Hong Kong); Health and Medical Research Fund (Hong Kong) and National Natural Science Foundation of China. She has published over 60 peer-reviewed articles and three book chapters on drug delivery. She has six PhD students graduated under her supervision, with five postgraduate students currently under her primary supervision.